Reuters Market Eye - Venus Remedies Ltd (VENR.NS) shares surge as much as 14.9 percent.
Venus will collaborate with Teva Pharmaceutical Industries Ltd (TEVA.TA) to develop an anti-cancer drug, it said in a statement on Tuesday. (http://bit.ly/1tBRHtj)
The company did not provide financial details of the deal.
(Reporting by Dipika Lalwani)
Red Lobster may be headed toward bankruptcy, but its business problems go far beyond all-you-can-eat shrimp.
BlackRock has a plan for your retirement savings: A 401(k) plan that comes with a monthly check for life. The firm's LifePath Paycheck takes a portion of an employee's retirement savings, and invests it in annuity contracts.
Dividend Aristocrats, a group of S&P 500 companies that have consistently increased their annual dividend payouts for at least 25 consecutive years, are often considered a haven for income-seeking investors. These companies are known for their ...
CVS warns it could cede Medicare Advantage market share as reimbursement rates pressure the company.
Imagine your child is getting married and you want to help pay for their wedding. You’ve been saving for years and now have $30,000 set aside for their big day, which you plan to hand over in the form of a check. However, before you pass along that much cash, it’s important to understand the […] The post Do I Need to Worry About the Gift Tax If I Pay $30,000 Toward My Child's Wedding? appeared first on SmartReads by SmartAsset.
We expect Palantir Technologies (PLTR) to report strong top and bottom lines in the first quarter of 2024.
Fed day arrives with the focus on what clues Powell will offer to the chances for rate cuts this year.
While ethical investors may opt to steer clear, top tobacco stock Altria Group currently boasts the highest dividend in the S&P 500 with a smoking-hot yield. Altria, best known for its iconic Marlboro cigarettes, was formed from a 2007 spinoff from Philip Morris. Altria took control of U.S. tobacco interests, prioritizing dividend growth and share buybacks, while Philip Morris focused on the international market.
Pfizer had a surprise beat in its COVID portfolio despite dim forecasts, but the company is still not feeling the love in its stock.
This is one of the most reliable cash-generating companies on the stock market.